A Trial of Degarelix in Patients With Prostate Cancer

Update Il y a 4 ans
Reference: NCT00946920

Extract

A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.


Inclusion criteria

  • Prostate cancer


Links